Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process.
about
sameAs
Pharmacogenomics in the clinicEconomic evaluations of personalized medicine: existing challenges and current developmentsSerotonergic gene variation in substance use pharmacotherapy: a systematic reviewPharmacogenetics and outcome with antipsychotic drugsEvidence synthesis and guideline development in genomic medicine: current status and future prospectsUse of contemporary genetics in cardiovascular diagnosisGenetics of Common Antipsychotic-Induced Adverse EffectsRecommendations for Optimizing Tuberculosis Treatment: Therapeutic Drug Monitoring, Pharmacogenetics, and Nutritional Status ConsiderationsIncidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are AvailableElectronic Medical Record-Integrated Pharmacogenomics and Related Clinical Decision Support Concepts.Assessment of patient perceptions of genomic testing to inform pharmacogenomic implementation.Bringing clinical pharmacogenomics information to pharmacists: A qualitative study of information needs and resource requirements.Analyzing the potential for incorrect haplotype calls with different pharmacogenomic assays in different populations: a simulation based on 1000 Genomes data.Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE networkPharmacogenetic testing revisited: 5' nuclease real-time polymerase chain reaction test panels for genotyping CYP2D6 and CYP2C19.Defining Disease, Diagnosis, and Translational Medicine within a Homeostatic Perturbation Paradigm: The National Institutes of Health Undiagnosed Diseases Program Experience.Integrating clinical decision support systems for pharmacogenomic testing into clinical routine - a scoping review of designs of user-system interactions in recent system development.Development of a postgraduate year 2 pharmacy residency in clinical pharmacogenetics.Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.A Template for Authoring and Adapting Genomic Medicine Content in the eMERGE Infobutton ProjectProspective participant selection and ranking to maximize actionable pharmacogenetic variants and discovery in the eMERGE Network.Preemptive clinical pharmacogenetics implementation: current programs in five US medical centersPrenatal antidepressant exposure associated with CYP2E1 DNA methylation change in neonates.Antidepressant prescribing in the precision medicine era: a prescriber's primer on pharmacogenetic tools.Pharmacogenetics: Using Genetic Information to Guide Drug Therapy.Creating Shareable Clinical Decision Support Rules for a Pharmacogenomics Clinical Guideline Using Structured Knowledge Representation.Examining perceptions of the usefulness and usability of a mobile-based system for pharmacogenomics clinical decision support: a mixed methods study.Pharmacogenetics for Safe Codeine Use in Sickle Cell Disease.PGRNseq: a targeted capture sequencing panel for pharmacogenetic research and implementation.Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)Polymorphism in CYP2D6 and CYP2C19, members of the cytochrome P450 mixed-function oxidase system, in the metabolism of psychotropic drugs.Combining genetic and nongenetic biomarkers to realize the promise of pharmacogenomics for inflammatory diseases.The role of ADME pharmacogenomics in early clinical trials: perspective of the Industry Pharmacogenomics Working Group (I-PWG).A decade of pharmacogenomics research on tyrosine kinase inhibitors in metastatic renal cell cancer: a systematic review.Advances in understanding genomic markers and pharmacogenetics of Parkinson's disease.Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.Pharmacogenetics: Implications for Modern Type 2 Diabetes Therapy.Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.PharmGKB summary: sorafenib pathways.Developing knowledge resources to support precision medicine: principles from the Clinical Pharmacogenetics Implementation Consortium (CPIC).
P2860
Q26782786-F460D3F7-C0A7-4D9E-86EF-DF21D92FA156Q26797183-4E8C0F32-F653-4EF2-8530-247C25BE3D49Q26799093-E2F6D669-1D89-45C1-88C3-73017EFD718BQ26852807-699C50F0-714A-4204-B303-93428D4915AFQ27010101-20FC5071-EF98-4AF2-8C9E-C61CAB7D1437Q27025306-7C3B83C1-A0E9-4344-8CF0-5C40F6CA2A7FQ28072893-97583C16-FC9B-44AF-A5A8-E368FFCA106BQ28079207-7DA9B162-C4DC-4A7D-9F48-31D724BD77E4Q28552832-87153F27-2F5F-40E3-B485-81E4B060BF5CQ30234897-9EFD4FB6-B227-4FC8-82FC-B2E1A726A05EQ30491071-57DD898F-4301-409C-972B-927E1F9CFA0BQ30699715-4B9724D3-E53E-47EE-85D9-C9BE4EC03008Q30999121-845FB9C9-A9F9-4F7C-BAF1-228C4C5F3B85Q31043647-3D702955-A189-4421-B699-2AE36872FB6EQ33597438-CD96948C-FE92-4C21-868F-5EA9F9E1C610Q33729428-F7F1F73E-0424-4275-A147-D3FF97F448E5Q33771344-9D6EEDD2-8E96-4564-8B07-ACD1952ACBC1Q33877987-C481A5EB-A8FF-476E-868F-6A58D7CBF048Q34550417-98C33BFF-171C-402C-9C8A-5F9EFE54144DQ35570210-6C06D01F-29B5-419D-AE13-489B12E39FE7Q35896022-663C3E28-8C04-4AC2-8E57-424FBC3CCCC9Q36166107-116FABCE-0BBC-424C-B99D-F055BE488D4EQ36213523-988C411D-499A-415B-B990-509B96BEFC0DQ36274662-F6362A7D-5525-472A-ACDF-A2A50BC15E03Q36508972-193B2C58-608F-49D0-83D4-EACD7356D545Q36613405-E0ABB08B-1CAC-4EA3-B399-13AE5247D918Q36623055-39BDE513-67B4-4EA7-AA7A-39BA692BD486Q37047429-0C816920-8B23-4999-88B3-F28FC9B9582EQ37072158-2159C083-1C87-49E0-8D25-14E70402E21EQ37597647-CC2CA051-9F8E-4427-81FC-D71BD200E42DQ38258243-E1D11894-BDBC-4385-9DCE-219DB0E2A85AQ38286234-35D6D0A7-24B9-4237-BD10-D22BADAB5E7DQ38652069-C0DB84F9-26B8-4670-A8AD-44839CC4F1EAQ38720430-18ADEC2E-E0F1-40B9-A43A-B6D953E918A4Q38748158-663F657B-8147-4536-B5B9-94168C545A14Q38753775-E71AA52B-F555-4AAF-BDBF-A967CAC705A2Q38816602-03BFAD54-0E6E-47D2-9B02-3EDD470C0B47Q38838757-E668ACC3-FBA8-4B7A-AE32-7FBE0AEDB9B8Q38864682-2C7AF13B-80F0-403F-ADFF-128081C43C45Q38888585-3D0A9AF8-C440-4591-BCDF-597ED01DC876
P2860
Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Incorporation of pharmacogenom ...... guideline development process
@nl
Incorporation of pharmacogenom ...... guideline development process.
@ast
Incorporation of pharmacogenom ...... guideline development process.
@en
type
label
Incorporation of pharmacogenom ...... guideline development process
@nl
Incorporation of pharmacogenom ...... guideline development process.
@ast
Incorporation of pharmacogenom ...... guideline development process.
@en
prefLabel
Incorporation of pharmacogenom ...... guideline development process
@nl
Incorporation of pharmacogenom ...... guideline development process.
@ast
Incorporation of pharmacogenom ...... guideline development process.
@en
P2093
P2860
P50
P3181
P1476
Incorporation of pharmacogenom ...... guideline development process.
@en
P2093
C Michael Stein
Caroline F Thorn
Daniel J Muller
James M Hoffman
Jesse J Swen
Katrin Sangkuhl
Kelly E Caudle
Kristine R Crews
P2860
P304
P3181
P356
10.2174/1389200215666140130124910
P407
P50
P577
2014-02-01T00:00:00Z